Company Filing History:
24 out of 64 
3 out of 40 
2 out of 145 
Years Active: 2008-2023
Title: **Marie Kosco-Vilbois: Pioneering Innovations in Monoclonal Antibodies**
Introduction
Marie Kosco-Vilbois, hailing from Minzier, France, is a distinguished inventor renowned for her significant contributions to the field of monoclonal antibodies. With a remarkable portfolio of 30 patents, she has been instrumental in advancing therapeutic solutions that target various cellular mechanisms, thus making substantial impacts in the biomedical arena.
Latest Patents
Among her latest patents are groundbreaking inventions, such as anti-CD47 antibodies and methods of use thereof. This invention involves the development of monoclonal and/or monovalent antibodies that effectively bind to CD47, as well as antibodies that target CD19. Additionally, it includes the innovation of bispecific monoclonal antibodies, designed to exhibit different specificities for each binding site on the immunoglobulin molecule, with one site targeting CD47 and another targeting CD19. Another notable patent pertains to anti-IL-6/IL-6R antibodies and their methods of use, which encompass fully human monoclonal antibodies capable of recognizing the IL-6/IL-6R complex. These advances pave the way for therapeutic, diagnostic, and prophylactic applications in modern medicine.
Career Highlights
Throughout her illustrious career, Marie has held pivotal roles in several esteemed organizations. Notably, she has worked with Novimmune SA, where her research contributed significantly to the development of innovative therapeutic solutions. Additionally, her tenure at Laboratoires Serono S.A. further showcases her commitment to pushing the boundaries of scientific research in the biopharmaceutical sector.
Collaborations
Marie Kosco-Vilbois has collaborated with outstanding professionals throughout her career. Among her notable coworkers are Nicolas Fischer and Greg Elson, who have shared in her vision of advancing healthcare through innovation. Their collective expertise has enhanced the development and implementation of cutting-edge antibody therapies.
Conclusion
In conclusion, Marie Kosco-Vilbois stands out as a leading figure in the field of monoclonal antibody research. Her extensive patent portfolio and collaborative efforts reflect her dedication to scientific advancement and innovation within the biomedical field. Through her work, she continues to inspire future generations of inventors and researchers.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.